KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $19,060,000 | +104.3% | 106,000 | +17.8% | 5.38% | +56.0% |
| Q2 2017 | $9,330,000 | +179.7% | 90,000 | +111.8% | 3.45% | +75.4% |
| Q1 2017 | $3,336,000 | -20.9% | 42,500 | -54.8% | 1.97% | -43.5% |
| Q4 2016 | $4,215,000 | -16.2% | 94,000 | +4.4% | 3.48% | -14.5% |
| Q3 2016 | $5,027,000 | +38.7% | 90,000 | +24.1% | 4.07% | +12.8% |
| Q2 2016 | $3,625,000 | +5.3% | 72,500 | -3.3% | 3.61% | -8.7% |
| Q1 2016 | $3,443,000 | +86.2% | 75,000 | +150.0% | 3.95% | +141.9% |
| Q4 2015 | $1,849,000 | – | 30,000 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |